Displaying 1 - 1 of 1
Active Ingredient BRIMONIDINE | TIMOLOL
Therapeutic Class ANTIGLAUCOMA AGENTS MISCELLANEOUS
Indications Reduction of intraocular pressure (IOP) in patients, with
progression of glaucoma or ocular hypertension, who are
insufficiently responsive to topical B-blockers.
Caution Ocular stinging, ocular pain, pruritus headache, conjunctival hyperemia, and conjunctival inflammation.
Dose Range One drop into the affected eye twice a day .
Drug Interactions
Pregnancy
Breast Feeding